Amongst the overall declining stock market, you might guess that there were a few cheeky winners who rebelled and rose in prices this thanksgiving. Cue the booster stocks who secured a big win on Monday, with Covid vaccine companies announcing strain testing.
Moderna (MRNA) and FDA-approved Pfizer (PFE) announced that Omnicron might have the last laugh, as the teams are already geared up to test the effectiveness of current vaccines against the new strain.
And if worse comes to worst, we might even find new vaccine formulas specifically targeting the Omicron variant by early 2022.
This caused a bump in Moderna shares by 10% combined with a 1% rise in Pfizer prices, while the market made way to recovering its holiday panic spelldown.